ZA200710384B - Immunogenic compositions for chlamydia trachomatis - Google Patents
Immunogenic compositions for chlamydia trachomatisInfo
- Publication number
- ZA200710384B ZA200710384B ZA200710384A ZA200710384A ZA200710384B ZA 200710384 B ZA200710384 B ZA 200710384B ZA 200710384 A ZA200710384 A ZA 200710384A ZA 200710384 A ZA200710384 A ZA 200710384A ZA 200710384 B ZA200710384 B ZA 200710384B
- Authority
- ZA
- South Africa
- Prior art keywords
- immunogenic compositions
- chlamydia trachomatis
- trachomatis
- chlamydia
- immunogenic
- Prior art date
Links
- 241000606153 Chlamydia trachomatis Species 0.000 title 1
- 229940038705 chlamydia trachomatis Drugs 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68072505P | 2005-05-12 | 2005-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200710384B true ZA200710384B (en) | 2009-08-26 |
Family
ID=37570936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200710384A ZA200710384B (en) | 2005-05-12 | 2007-11-29 | Immunogenic compositions for chlamydia trachomatis |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8133973B2 (fr) |
| EP (1) | EP1891096A2 (fr) |
| JP (1) | JP2008544745A (fr) |
| KR (1) | KR20080024125A (fr) |
| CN (1) | CN101238146A (fr) |
| AU (1) | AU2006259858A1 (fr) |
| CA (1) | CA2608278A1 (fr) |
| RU (1) | RU2007146137A (fr) |
| WO (1) | WO2006138004A2 (fr) |
| ZA (1) | ZA200710384B (fr) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US7082569B2 (en) | 2001-01-17 | 2006-07-25 | Outlooksoft Corporation | Systems and methods providing dynamic spreadsheet functionality |
| CN1812809A (zh) * | 2003-06-26 | 2006-08-02 | 希龙公司 | 用于沙眼衣原体的免疫原性组合物 |
| US8541007B2 (en) | 2005-03-31 | 2013-09-24 | Glaxosmithkline Biologicals S.A. | Vaccines against chlamydial infection |
| NZ591768A (en) | 2008-09-18 | 2012-11-30 | Novartis Ag | Vaccine adjuvant combinations |
| ITMI20090946A1 (it) | 2009-05-28 | 2010-11-29 | Novartis Ag | Espressione di proteine ricombinanti |
| CN102740882A (zh) | 2009-08-27 | 2012-10-17 | 诺华有限公司 | 含有铝、寡核苷酸和聚阳离子的佐剂 |
| ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
| GB201009861D0 (en) | 2010-06-11 | 2010-07-21 | Novartis Ag | OMV vaccines |
| RS63817B1 (sr) | 2010-07-06 | 2023-01-31 | Glaxosmithkline Biologicals Sa | Čestice za isporuku slične virionu za molekule samoreplicirajuće rnk |
| US9770463B2 (en) | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| HUE026646T2 (en) | 2010-07-06 | 2016-07-28 | Glaxosmithkline Biologicals Sa | Preferred liposomes containing lipids of PKA value for delivery of RNA |
| PL2591114T3 (pl) | 2010-07-06 | 2017-08-31 | Glaxosmithkline Biologicals Sa | Immunizacja dużych ssaków małymi dawkami rna |
| HUE047796T2 (hu) | 2010-07-06 | 2020-05-28 | Glaxosmithkline Biologicals Sa | RNS bevitele több immunútvonal bekapcsolására |
| PT3970742T (pt) | 2010-08-31 | 2022-06-27 | Glaxosmithkline Biologicals Sa | Lipossomas peguilados para entrega de arn codificador de imunogénio |
| ES2727583T3 (es) | 2010-08-31 | 2019-10-17 | Glaxosmithkline Biologicals Sa | Lípidos adecuados para la administración liposómica de ARN que codifica proteínas |
| ES2458355T3 (es) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorción de inmunopotenciadores sobre sales metálicas insolubles |
| JP2013544504A (ja) | 2010-10-11 | 2013-12-19 | ノバルティス アーゲー | 抗原送達プラットフォーム |
| US9618508B2 (en) | 2010-12-14 | 2017-04-11 | Glaxosmithkline Biologicals Sa | Flow cytometry analysis of materials adsorbed to metal salts |
| US10286056B2 (en) | 2011-01-27 | 2019-05-14 | Glaxosmithkline Biologicals S.A. | Adjuvant nanoemulsions with crystallisation inhibitors |
| WO2012117377A1 (fr) | 2011-03-02 | 2012-09-07 | Novartis Ag | Vaccins combinés comprenant des doses inférieures d'antigène et/ou d'adjuvant |
| WO2012129483A1 (fr) | 2011-03-24 | 2012-09-27 | Novartis Ag | Nanoémulsions adjuvantes avec des phospholipides |
| WO2013006838A1 (fr) | 2011-07-06 | 2013-01-10 | Novartis Ag | Compositions de combinaisons immunogènes et utilisations de celles-ci |
| US20140141070A1 (en) | 2011-07-06 | 2014-05-22 | Andrew Geall | Liposomes having useful n:p ratio for delivery of rna molecules |
| EP3508220A1 (fr) | 2011-08-31 | 2019-07-10 | GlaxoSmithKline Biologicals S.A. | Liposomes pégylés pour l'administration d'arn codant un immunogène |
| MX346678B (es) | 2012-03-07 | 2017-03-29 | Novartis Ag | Sales de arginina utiles inmunologicamente. |
| JP2015510872A (ja) | 2012-03-07 | 2015-04-13 | ノバルティス アーゲー | Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤 |
| MX372965B (es) | 2012-03-08 | 2020-04-01 | Glaxosmithkline Biologicals Sa | Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo. |
| US9764027B2 (en) | 2012-09-18 | 2017-09-19 | Glaxosmithkline Biologicals Sa | Outer membrane vesicles |
| EP3608308B1 (fr) | 2013-03-08 | 2021-07-21 | Novartis AG | Lipides et compositions lipidiques pour l'administration d'agents actifs |
| ES2895651T3 (es) | 2013-12-19 | 2022-02-22 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
| EP4019506A1 (fr) | 2013-12-19 | 2022-06-29 | Novartis AG | Lipides et compositions lipidiques pour l'administration d'agents actifs |
| EP3169309B1 (fr) | 2014-07-16 | 2023-05-10 | Novartis AG | Procédé d'encapsulation d'un acide nucléique dans une nanoparticule lipidique hôte |
| US10125092B2 (en) | 2014-09-05 | 2018-11-13 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| EP3061826A1 (fr) | 2015-02-27 | 2016-08-31 | Novartis AG | Réplicons du flavivirus |
| CN111748021B (zh) * | 2020-06-09 | 2021-09-07 | 温州医科大学 | 一种对沙眼衣原体momp具有结合亲和力的多肽及其应用 |
| JP2023546175A (ja) | 2020-10-14 | 2023-11-01 | ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド | 脂質ナノ粒子製造の方法及びそれに由来する組成物 |
| WO2023021427A1 (fr) | 2021-08-16 | 2023-02-23 | Glaxosmithkline Biologicals Sa | Lyophilisation de nanoparticules lipidiques (lnp) encapsulant de l'arn et leurs formulations |
| WO2023021421A1 (fr) | 2021-08-16 | 2023-02-23 | Glaxosmithkline Biologicals Sa | Vaccins à base d'arn lyophilisés à faible dose et leurs procédés de préparation et d'utilisation |
| GB202303019D0 (en) | 2023-03-01 | 2023-04-12 | Glaxosmithkline Biologicals Sa | Method of lyophilisation |
| GB202311382D0 (en) | 2023-07-25 | 2023-09-06 | Glaxosmithkline Biologicals Sa | Lyophilised compostion |
| WO2026033498A1 (fr) | 2024-08-09 | 2026-02-12 | Genvax Technologies, Inc. | Procédés de fabrication de nanoparticules lipidiques-arn auto-amplififié et compositions dérivées de celles-ci |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100735651B1 (ko) * | 1997-11-28 | 2007-07-06 | 세로노 제네틱스 인스티튜트 에스.에이. | 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| CN1812809A (zh) | 2003-06-26 | 2006-08-02 | 希龙公司 | 用于沙眼衣原体的免疫原性组合物 |
| ES2389562T3 (es) | 2004-10-25 | 2012-10-29 | Statens Seruminstitut | Antígenos de Chlamydia trachomatis para uso en vacuna y diagnóstico |
| EP2386314A1 (fr) | 2005-03-31 | 2011-11-16 | GlaxoSmithKline Biologicals SA | Vaccins contre l'infection à chlamydia |
-
2006
- 2006-05-12 EP EP06799913A patent/EP1891096A2/fr not_active Withdrawn
- 2006-05-12 JP JP2008511422A patent/JP2008544745A/ja not_active Withdrawn
- 2006-05-12 CN CNA2006800242930A patent/CN101238146A/zh active Pending
- 2006-05-12 KR KR1020077028988A patent/KR20080024125A/ko not_active Ceased
- 2006-05-12 US US11/920,230 patent/US8133973B2/en not_active Expired - Fee Related
- 2006-05-12 RU RU2007146137/13A patent/RU2007146137A/ru not_active Application Discontinuation
- 2006-05-12 WO PCT/US2006/018504 patent/WO2006138004A2/fr not_active Ceased
- 2006-05-12 AU AU2006259858A patent/AU2006259858A1/en not_active Abandoned
- 2006-05-12 CA CA002608278A patent/CA2608278A1/fr not_active Abandoned
-
2007
- 2007-11-29 ZA ZA200710384A patent/ZA200710384B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006259858A1 (en) | 2006-12-28 |
| EP1891096A2 (fr) | 2008-02-27 |
| WO2006138004A2 (fr) | 2006-12-28 |
| RU2007146137A (ru) | 2009-06-27 |
| JP2008544745A (ja) | 2008-12-11 |
| CN101238146A (zh) | 2008-08-06 |
| KR20080024125A (ko) | 2008-03-17 |
| CA2608278A1 (fr) | 2006-12-28 |
| US8133973B2 (en) | 2012-03-13 |
| WO2006138004A3 (fr) | 2007-04-12 |
| US20110158977A1 (en) | 2011-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200710384B (en) | Immunogenic compositions for chlamydia trachomatis | |
| AP2436A (en) | Immunogenic composition | |
| IL191572A0 (en) | Pestcidal compositions | |
| IL186721A0 (en) | Bioenhanced compositions | |
| GB0503337D0 (en) | Compositions | |
| IL186093A0 (en) | Lignan-containing compositions | |
| EP1874345A4 (fr) | Compositions immunostimulantes | |
| GB0526038D0 (en) | Immunogenic composition | |
| GB0526283D0 (en) | Compositions | |
| GB0501365D0 (en) | Compositions | |
| ZA200710909B (en) | Immunogenic composition | |
| GB0524128D0 (en) | Compositions | |
| ZA200709913B (en) | Bioenhanced compositions | |
| GB0526282D0 (en) | Compositions | |
| ZA200710854B (en) | Immunogenic composition | |
| GB0402236D0 (en) | Immunogenic compositions for chlamydia trachomatis | |
| GB0501364D0 (en) | Compositions | |
| GB0315020D0 (en) | Immunogenic compositions for chlamydia trachomatis | |
| GB0506065D0 (en) | Compositions | |
| GB0525138D0 (en) | Compositions | |
| GB0512972D0 (en) | Compositions | |
| GB0500076D0 (en) | Compositions | |
| GB0505989D0 (en) | Compositions | |
| GB0503356D0 (en) | Compositions | |
| GB0506004D0 (en) | Compositions |